Yüklüyor......

Clinical outcomes of patients with mitral prosthetic valve obstructive thrombosis treated with streptokinase or tenecteplase

Agent of choice for thrombolytic therapy (TT) in prosthetic valve thrombosis (PVT) is unknown. 84 mitral obstructive-PVT episodes treated with TT (43: Tenecteplase; 41: Streptokinase) were included in this prospective study. The incidence of primary end-point (CCS: complete clinical success, defined...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Indian Heart J
Asıl Yazarlar: Kiran, G. Ravi, Chandrasekhar, P., Mohammad Ali, S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2021
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8322749/
https://ncbi.nlm.nih.gov/pubmed/34154758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2021.02.005
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!